Well. Thats really not good news for holders. Type A rejected. ARDS failed etc etc.
MSB has so far very unfortunately failed to deliver a product that can be approved to market. Condolences to those still holding.
As some may or may not remember I left and sold for a bit of a loss when MSB got rejected for Revasacor. I had held for over 6+ years prior to but I made a firm decision I would not hold the stock if they ever got rejected.
The fact they got rejected on the drug that was supposed to be the "gimme free win" was shocking.
So the ARDS result now unfortunately does not surprise me. I wish it had been opposite though I would have considered coming back in.
Real shame for anybody still in the stock as they have consistently demonstrated failure at the final hurdles on a few occasions now.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-25
-
- There are more pages in this discussion • 1,051 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.025(2.29%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.06 | $4.942M | 4.613M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 70659 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 43531 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |